SCHEMBL22929108

SCHEMBL22929108

COc1nc2ccccc2nc1O[SiH3]

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 4/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HRH4 Q9H3N8 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
HDAC6 Q9UBN7 1/20 0.45
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 3/20 0.44
POLB P06746 2/20 0.44
LMNA P02545 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MAPT P10636 2/20 0.42
TSHR P16473 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2C9 P11712 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7474377 0.89 NQO2 (0.56) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL804981 0.76 TSHR (0.61) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL7048658 0.74 CYP1A2 (0.58) KMT2AL3MBTL1HDAC6ALDH1A1KDM4E
SCHEMBL4684319 0.74 KDM4E (0.58) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL12498159 0.74 NQO2 (0.47) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL5574299 0.74 NQO2 (0.47) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL6873559 0.74 NQO2 (0.47) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL14624137 0.74 NQO2 (0.52) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL2178510 0.74 TDP1 (0.58) NQO2MEN1KMT2AHRH4L3MBTL1
SCHEMBL8024194 0.71 NQO2 (0.44) NQO2MEN1KMT2AHRH4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10906921-B2 Base generator, reagent, organic salt, composition, method for manufacturing device, cured film and device TOYO GOSEI CO., LTD. (JP) 2021-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10906921-B2 Base generator, reagent, organic salt, composition, method for manufacturing device, cured film and device ASIC1, SEM1, RER1 NQO2 1379/4885MEN1 426/4885KMT2A 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.